The Chancellor,Masters And Scholars Of The University Of Cambridge investment portfolio

Cambridge GaN Devices Ltd is a fabless semiconductor company that designs, develops and commercialises gallium‑nitride (GaN) power transistors and integrated circuits, including its ICeGaN enhancement‑mode devices that operate like MOSFETs. Its products are aimed at automotive manufacturers and other sectors that require high‑efficiency, low‑loss power‑electronics solutions.

Immutrin Ltd is a biotechnology company developing a next‑generation antibody therapy that selectively removes systemic amyloid deposits, with its lead asset aimed at treating ATTR cardiomyopathy, a serious form of amyloidosis.